A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program

被引:210
|
作者
Mal, A
Sturniolo, M
Schiltz, RL
Ghosh, MK
Harter, ML
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA
[2] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA
来源
EMBO JOURNAL | 2001年 / 20卷 / 07期
关键词
HDAC1; MyoD; myogenic conversion; skeletal muscle cells;
D O I
10.1093/emboj/20.7.1739
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular mechanism(s) that are responsible for suppressing MyoD's transcriptional activities in undifferentiated skeletal muscle cells have not yet been determined. We now show that MyoD associates with a histone deacetylase-1 (HDAC1) in these cells and that this interaction is responsible for silencing MyoD-dependent transcription of endogenous p21 as well as muscle-specific genes. Specifically, we present evidence that HDAC1 can bind directly to MyoD and use an acetylated MyoD as a substrate in vitro, whereas a mutant version of HDAC1 (H141A) can not. Furthermore, this mutant also fails to repress MyoD-mediated transcription in vivo, and unlike wild-type HDAC1 it can not inhibit myogenic conversion, as judged by confocal microscopy. Finally, we show that an endogenous MyoD can be acetylated upon its conversion to a hypophosphorylated state and only when the cells have been induced to differentiate. These results provide for a model which postulates that MyoD may be co-dependent on HDAC1 and P/CAF for temporally controlling its transcriptional activity before and after the differentiation of muscle cells.
引用
收藏
页码:1739 / 1753
页数:15
相关论文
共 50 条
  • [11] Transport by SLC5A8 With Subsequent Inhibition of Histone Deacetylase 1 (HDAC1) and HDAC3 Underlies the Antitumor Activity of 3-bromopyruvate
    Thangaraju, Muthusamy
    Karunakaran, Senthil K.
    Itagaki, Shiro
    Gopal, Elangovan
    Elangovan, Selvakumar
    Prasad, Puttur D.
    Ganapathy, Vadivel
    CANCER, 2009, 115 (20) : 4655 - 4666
  • [12] Malat1 regulates myogenic differentiation and muscle regeneration through modulating MyoD transcriptional activity
    Xiaona Chen
    Liangqiang He
    Yu Zhao
    Yuying Li
    Suyang Zhang
    Kun Sun
    Karl So
    Fengyuan Chen
    Liang Zhou
    Leina Lu
    Lijun Wang
    Xihua Zhu
    Xichen Bao
    Miguel A Esteban
    Shinichi Nakagawa
    Kannanganattu V Prasanth
    Zhenguo Wu
    Hao Sun
    Huating Wang
    Cell Discovery, 3
  • [13] The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy
    Cao, Lin-Lin
    Yue, Zhihong
    Liu, Lianhua
    Pei, Lin
    Yin, Yue
    Qin, Li
    Zhao, Jie
    Liu, Huixin
    Wang, Hui
    Jia, Mei
    ONCOTARGET, 2017, 8 (24) : 39241 - 39253
  • [14] Malat1 regulates myogenic differentiation and muscle regeneration through modulating MyoD transcriptional activity
    Chen, Xiaona
    He, Liangqiang
    Zhao, Yu
    Li, Yuying
    Zhang, Suyang
    Sun, Kun
    So, Karl
    Chen, Fengyuan
    Zhou, Liang
    Lu, Leina
    Wang, Lijun
    Zhu, Xihua
    Bao, Xichen
    Esteban, Miguel A.
    Nakagawa, Shinichi
    Prasanth, Kannanganattu V.
    Wu, Zhenguo
    Sun, Hao
    Wang, Huating
    CELL DISCOVERY, 2017, 3
  • [15] The histone deacetylase Hdac1 regulates inflammatory signalling in intestinal epithelial cells
    Alexis Gonneaud
    Julie Moore Gagné
    Naomie Turgeon
    Claude Asselin
    Journal of Inflammation, 11
  • [16] The large subunit of replication factor C interacts with the histone deacetylase, HDAC1
    Anderson, LA
    Perkins, ND
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) : 29550 - 29554
  • [17] Interaction of EKLF with corepressor mSin3A and histone deacetylase 1 (HDAC1).
    Chen, XY
    Bieker, JJ
    BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (05) : 493 - 493
  • [18] HISTONE DEACETYLASE 1 (HDAC1): A NOVEL THERAPEUTIC TARGET IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Goeschl, L.
    Mueller, L.
    Saferding, V.
    Knapp, S.
    Backlund, J.
    Scheinecker, C.
    Smolen, J.
    Ellmeier, W.
    Steiner, G.
    Bonelli, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 264 - 265
  • [19] Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target for Patients with Rheumatoid Arthritis
    Goschl, Lisa
    Bonelli, Michael
    Saferding, Victoria
    Peglej, Teresa
    Knapp, Sylvia
    Backlund, Johan
    Bock, Christoph
    Matthias, Patrick
    Hirahara, Kiyoshi
    Scheinecker, Clemens
    Steiner, Guenter
    Smolen, Josef S.
    Ellmeier, Wilfried
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [20] The histone deacetylase Hdac1 regulates inflammatory signalling in intestinal epithelial cells
    Gonneaud, Alexis
    Gagne, Julie Moore
    Turgeon, Naomie
    Asselin, Claude
    JOURNAL OF INFLAMMATION-LONDON, 2014, 11